Takashima, K., Miyake, H., Kanzaki, N., Tagawa, Y., Wang, X., Sugihara, Y., . . . Baba, M. (2005). Highly Potent Inhibition of Human Immunodeficiency Virus Type 1 Replication by TAK-220, an Orally Bioavailable Small-Molecule CCR5 Antagonist. American Society for Microbiology.

Takashima, Katsunori, Hiroshi Miyake, Naoyuki Kanzaki, Yoshihiko Tagawa, Xin Wang, Yoshihiro Sugihara, Yuji Iizawa, and Masanori Baba. Highly Potent Inhibition of Human Immunodeficiency Virus Type 1 Replication By TAK-220, an Orally Bioavailable Small-Molecule CCR5 Antagonist. American Society for Microbiology, 2005.

Takashima, Katsunori, et al. Highly Potent Inhibition of Human Immunodeficiency Virus Type 1 Replication By TAK-220, an Orally Bioavailable Small-Molecule CCR5 Antagonist. American Society for Microbiology, 2005.